Discover the impact and mitigation strategies for CVE-2023-31923 affecting Suprema BioStar 2 software. Learn the technical details and steps to secure your systems.
A vulnerability in the Suprema BioStar 2 before 2022 Q4, v2.9.1 could allow an attacker to create a highly privileged user account. This article provides insights into the CVE-2023-31923, its impact, technical details, and mitigation steps.
Understanding CVE-2023-31923
This section delves into the details of the vulnerability present in the Suprema BioStar 2 software affecting versions before 2022 Q4, v2.9.1.
What is CVE-2023-31923?
The vulnerability in the web application of Suprema BioStar 2 allows an authenticated attacker with 'User Operator' privileges to create a highly privileged user account due to missing server-side validation.
The Impact of CVE-2023-31923
Exploiting this vulnerability can lead to an attacker gaining full administrator privileges on the system, posing a significant security risk.
Technical Details of CVE-2023-31923
This section outlines specific technical aspects of the CVE, including the vulnerability description, affected systems and versions, and the exploitation mechanism.
Vulnerability Description
The vulnerability in Suprema BioStar 2 before 2022 Q4, v2.9.1 is due to insecure permissions, enabling an authenticated attacker to elevate their privileges.
Affected Systems and Versions
The issue affects versions of Suprema BioStar 2 released before 2022 Q4, v2.9.1.
Exploitation Mechanism
An attacker with 'User Operator' privileges can exploit the missing server-side validation to create a user account with full administrator privileges.
Mitigation and Prevention
In this section, proactive steps to mitigate the risk posed by CVE-2023-31923 are discussed, offering immediate and long-term security practices.
Immediate Steps to Take
Users are advised to restrict access to vulnerable systems, monitor for any unauthorized account creations, and apply relevant security updates promptly.
Long-Term Security Practices
Implementing the principle of least privilege, conducting regular security audits, and educating users on safe authentication practices can enhance overall security posture.
Patching and Updates
Vendor-supplied patches and updates should be applied as soon as they are available to address the vulnerability in Suprema BioStar 2.